Literature DB >> 14609709

Ex vivo expansion of limbal epithelial stem cells: amniotic membrane serving as a stem cell niche.

Martin Grueterich1, Edgar M Espana, Scheffer C G Tseng.   

Abstract

Identification, maintenance, and expansion of stem cells for subsequent transplantation has become a new strategy for treating many diseases in most medical subspecialties. The stem cells of the corneal epithelium are located in the limbal basal layer and are the ultimate source for constant corneal epithelial renewal. Like those in other tissues, limbal stem cells are supported by a unique stromal microenvironment called the stem cell niche, which consists of certain extracellular matrix components, cell membrane-associated molecules, and cytokine dialogues. Destructive loss of limbal stem cells or dysfunction of their stromal environment renders many corneas with a clinical entity called limbal stem cell deficiency, which is characterized by variable extents of conjunctival ingrowth depending on the severity of limbal damage. A new strategy of treating limbal stem cell deficiency is to transplant a bio-engineered graft by expanding limbal epithelial stem cells ex vivo on amniotic membrane. This review summarizes the published literature data collectively explaining how amniotic membrane is an ideal biological substrate that can help maintain and support the expansion of limbal epithelial stem cells.

Mesh:

Substances:

Year:  2003        PMID: 14609709     DOI: 10.1016/j.survophthal.2003.08.003

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  65 in total

1.  Silk fibroin as a biomaterial substrate for corneal epithelial cell sheet generation.

Authors:  Jingbo Liu; Brian D Lawrence; Aihong Liu; Ivan R Schwab; Lauro A Oliveira; Mark I Rosenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-26       Impact factor: 4.799

2.  Epithelial proliferative potential of organ cultured corneoscleral rims; implications for allo-limbal transplantation and eye banking.

Authors:  V A Shanmuganathan; A P Rotchford; A B Tullo; A Joseph; I Zambrano; H S Dua
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

Review 3.  Niche regulation of corneal epithelial stem cells at the limbus.

Authors:  Wei Li; Yasutaka Hayashida; Ying-Ting Chen; Scheffer C G Tseng
Journal:  Cell Res       Date:  2007-01       Impact factor: 25.617

4.  The fate of limbal epithelial progenitor cells during explant culture on intact amniotic membrane.

Authors:  Wei Li; Yasutaka Hayashida; Hua He; Ching-Liang Kuo; Scheffer C G Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

5.  Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK user group.

Authors:  Valerie P J Saw; Darwin Minassian; John K G Dart; Andrew Ramsay; Hugo Henderson; Stefan Poniatowski; Ruth M Warwick; Suzanne Cabral
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

Review 6.  Critical appraisal of ex vivo expansion of human limbal epithelial stem cells.

Authors:  S C G Tseng; S-Y Chen; Y-C Shen; W-L Chen; F-R Hu
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

Review 7.  Epithelial stem cells of the eye surface.

Authors:  R P Revoltella; S Papini; A Rosellini; M Michelini
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

8.  Reversal of myofibroblasts by amniotic membrane stromal extract.

Authors:  Wei Li; Hua He; Ying-Ting Chen; Yasutaka Hayashida; Scheffer C G Tseng
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

Review 9.  [Short-term and long-term complications after transplantation of cultivated limbal epithelium].

Authors:  D Meller; H Thomasen; M-S Hanet; D Dekowski; S Scholz; K Amir; K-P Steuhl
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

10.  BALB/c and C57BL6 mouse strains vary in their ability to heal corneal epithelial debridement wounds.

Authors:  Sonali Pal-Ghosh; Gauri Tadvalkar; Rosalyn A Jurjus; James D Zieske; Mary Ann Stepp
Journal:  Exp Eye Res       Date:  2008-09-06       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.